...
首页> 外文期刊>The American heart journal >A randomized trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: Design of the Rapid Assessment of Possible ACS In the emergency Department with high sensitivity Troponin T (RAPID-TnT) study
【24h】

A randomized trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: Design of the Rapid Assessment of Possible ACS In the emergency Department with high sensitivity Troponin T (RAPID-TnT) study

机译:一种涉嫌急性冠状动脉综合征的1小时肌钙蛋白T律综合征的随机试验:高敏感性肌钙蛋白T(Rapid-TNT)研究的急诊科可能ACS快速评估设计

获取原文
获取原文并翻译 | 示例
           

摘要

Background Protocols incorporating high-sensitivity troponin to guide decision making in the disposition of patients with suspected acute coronary syndromes (ACS) in the emergency department have received a lot of attention. Traditionally, patients with chest pain have required long periods of observation in emergency department before being deemed safe for discharge. In an era of limited health service resources, a protocol that could discharge patients safely within an hour of presentation is extremely attractive. Unfortunately, despite incorporation into some guidelines, these protocols have not been subjected to randomized comparisons evaluating safety, effectiveness, and cost-effectiveness. Objective This study is designed to provide the evidence required to allow key decision makers to implement these protocols: specifically, to provide evidence that a decision rule based on 0- and 1-hour high-sensitivity troponin T (hs-TnT) is safe, provides noninferior outcomes in all patients with suspected ACS, and that implementation of a rapid troponin protocol leads to efficient care. Design This prospective pragmatic trial (n = 5,400, 5 hospitals) randomly allocates patients with suspected ACS to either a 0/1-hour hs-TnT protocol as advocated in clinical guidelines, versus usual care of standard troponin reporting evaluated at 3 and 6 hours. The primary effectiveness composite end points of this study are all-cause death and new/recurrent ACS within 30 days. To evaluate cost-effectiveness, follow-up will determine clinical events, quality of life, and resource utilization within 12 months. Summary Demonstrating that a 0/1-hour hs-TnT protocol improves the effectiveness and efficiency of care within a robust comparative study will fill an evidence gap that currently limits the translation of more precise hs-TnT testing into better patient and health service outcomes. ]]>
机译:结合高敏感性肌钙蛋白的背景协议,以指导急诊部中疑似急性冠状动脉综合征(ACS)的患者进行决策,得到了很多关注。传统上,在被视为放电的安全之前,胸痛患者在急诊部门长时间观察。在有限的健康服务资源的时代,可以在一个小时内安全地放电患者的议定书非常有吸引力。遗憾的是,尽管纳入了一些指导方针,但这些协议尚未经过随机比较评估安全性,有效性和成本效益。目的旨在提供允许关键决策者实施这些议定书所需的证据:具体而言,提供了基于0-和1小时高敏感性肌钙蛋白T(HS-TNT)的决策规则的证据,在所有疑似ACS患者中提供非患者的非流动结果,并且这种快速肌钙蛋白议定书的实施导致有效的护理。设计这一前瞻性务实试验(N = 5,400,5家医院)随机分配疑似ACS的患者,以0/1小时HS-TNT协议,如临床指南所倡导,通常护理标准肌钙蛋白报告3小时和6小时评估。本研究的主要效果综合终点是全部导致死亡和新的/经常性ACS在30天内。为了评估成本效益,随访将确定12个月内的临床事件,生活质量和资源利用。摘要表明,0/1小时HS-TNT协议提高了稳健的比较研究中护理的有效性和效率将填补目前将更精确的HS-TNT测试的翻译限制为更好的患者和卫生服务成果。 ]]>

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号